A pilot study evaluating its use in advanced dry agerelated macular degeneration is currently underway, and this device may also prove to benefit other retinal degenerations. Apr 12, 2018 in early testing, a bioengineered retinal implant appears to be safe for use in humans and may be effective in treating vision loss caused by one type of macular degeneration. Feb 24, 2016 a retinal implant system that is capable of restoring some sight to adults who have lost their vision due to retinitis pigmentosa. Practical concepts with the argus ii retinal prosthesis. Aug 19, 20 on august 15, 20, second sight medical products, inc.
Pracical reina practical concepts with the argus ii. For patients with retinitis pigmentosa rp, you may qualify for this procedure that partially restores vision continue reading. The procedure is performed by an experienced retinal surgeon, with second sight technicians available for your support. The argus ii retinal prosthesis system is one such artificial vision device. The argus ii retinal implant, manufactured by second sight medical products. The replacement parts must be billed to the ab mac. The argus i artificial retina model has already undergone human implant tests. The argus ii device second sight medical products is the only fdaapproved epiretinal implant at this time.
The argus ii retinal prosthesis system was the first of its kind to receive regulatory approval for commercial use in europe and the usa. The costeffectiveness of the argus ii retinal prosthesis in. Apr 06, 2018 our study shows that this unique stem cellbased retinal implant thus far is welltolerated, and preliminary results suggest it may help people with advanced dry agerelated macular degeneration, said coauthor and lead inventor of the implant dr. Intraoperative oct imaging of the argus ii retinal. Argus ii retinal implant successfully completes clinical trial. When daughter opal read the letter to him, they discussed it thoroughly before deciding that he, indeed, would like to have an evaluation. We extend an invitation to readers to submit pearls for publication in retina today. The argus ii retinal prosthesis system eyecare tomorrow. The argus ii system has already been studied in completely blind patients with retinitis pigmentosa rp. Costeffectiveness of the argus ii retinal prosthesis. He is using a retinal implant which converts video images from a. Argus ii retinal prosthesis system dry amd feasibility. Retinitis pigmentosa rp is a group of heterogeneous inherited retinal degenerative disorders characterized by progressive rod and cone.
Feb 29, 2016 emory eye center offers argus ii retinal prosthesis system duration. A clinical trial enrolling 5 subjects with severe agerelated macular degeneration is currently. Copenhagen the argus ii retinal prosthesis system implanted in patients with dry agerelated macular degeneration proved effective in. Argus ii retinal prosthesis implantation using three. The argus ii was the first retinal implant to receive ce marking, and the only implant granted an fda approval as a humanitarian use device.
Second sight announces positive fiveyear data from argus ii retinal prosthesis system. While competing retinal implants generally target rare conditions involving. In 2002, argus i, the first iteration of the device, which had 16 microelectrodes, was tested on human subjects who were enrolled in a phase 1 clinical trial. Adapted surgical procedure for argus ii retinal implantation. The argus ii is the only retinal implant to have been approved for sale in the european economic area, the us, and canada. The argus ii retinal prosthesis system argus ii second sight medical products, inc, sylmar, ca was approved by the food and drug administration in 20 for patients with retinitis pigmentosa and visual acuity of bare light perception or worse. Retina posted 8920 the implantation procedure is shown in this video. Sep 05, 2018 in addition to argus ii retinal implant, the iris 2 pixium and alphaams retina implant devices have received the eu ce mark hornig et al. In early testing, a bioengineered retinal implant appears to be safe for use in humans and may be effective in treating vision loss caused by one type of macular degeneration. The device may help adults with rp who have lost the ability to perceive shapes and movement to be more mobile and to perform daytoday activities. Surgical pearls for implantation of the argus ii retinal.
Rp is a leading cause of blindness resulting in incurable visual impairment and drastic reduction in the quality of life of the patients. Retinal diseases like, agerelated macular degeneration and retinitis pigmentosa decrease vision by destroying the lightsensitive photoreceptor cells in the retina. The argus ii retinal prosthesis system njretinanjretina. Is there any published data about the argus ii results. The argus ii epiretinal prosthesis second sight medical products inc. Second sight announces first agerelated macular degeneration patient receives the argus ii retinal prosthesis system as part of groundbreaking study. The argus ii retinal prosthesis system sciencedirect. A pilot study evaluating its use in advanced dry agerelated macular degeneration is currently underway, and this device may also prove to benefit other. Retinal implants could restore sight to more than 2 million people human trials are on the horizon for the potentially lifechanging tech. A third epiretinal device, epiret, has been developed and progressed to clinical testing in six patients. Research is ongoing, and has documented improvement in visual acuity best achieved 201,262 and task completion with the 60electrode array. Retinal implants could restore sight to more than 2. The argus ii retinal prosthesis system second sight medical products is the first prosthetic vision device to obtain regulatory approval in both europe and the usa.
Humayun, director of the usc institute for biomedical therapeutics and codirector. The argus ii retinal prosthesis system is one such artificial vision device approved for patients with rp. Retinal implant technologies are just emerging, and the argus ii is currently marketed as a complementary device to the long cane and guide dog for complex tasks, such as orientation and mobility. Currently, it has been implanted in more than 70 patients. Fda approves worlds first artificial retina the american. This is a gamechanger in sightaffecting diseases, that represents a huge step forward for the field and for these patients who were without any. In addition to argus ii retinal implant, the iris 2 pixium and alphaams retina implant devices have received the eu ce mark hornig et al.
Study pioneers implantation of argus ii in patients with advanced dry. May 16, 2017 the argus ii is the only retinal implant to have been approved for sale in the european economic area, the us, and canada. In this issue of retina today, marco mura, md, and giulio bamonte, md, discuss pearls for implantation of the argus ii retinal prosthesis system second sight medical products. Argus ii retinal implant bionic eye retinal prosthesis system. Fda approves first retinal implant scientific american. The argus ii retinal prosthesis aims to restore vision in patients with profound vision loss due to endstage retinal degenerative diseases such as retinitis pigmentosa. Agerelated macular degeneration patient receives bionic. Currently marketed implants such as second sights argus ii. Implanting the argus ii is a well established surgery, typically taking only a few hours.
The first recipient with dry amd, ray flynn, was fitted with the implant june 16, 2015. Agerelated macular degeneration patient receives bionic eye transplant by chris wood. Mar 15, 20 after more than 20 years of research and development, second sight medical products announced that its argus ii retinal prosthesis system has received u. The functional performance of the argus ii retinal prosthesis. Once implanted, the argus ii implant sits in and around the back of the eye and is not visible to others. Apr 14, 2014 retinitis pigmentosa rp is a hereditary genetic disease causing bilateral retinal degeneration. In subjects with agerelated macular degeneration, who may have intact peripheral vision, retinal implants could result in a hybrid form of vision. After more than 20 years of research and development, second sight medical products announced that its argus ii retinal prosthesis system has received u. The device is designed to replicate the function of photoreceptors in converting visual information into electrical neural signals in patients with profound visual loss secondary to degenerative retinal disease. It is the most widely used retinal prosthesis worldwide, with over 250 patients estimated to have undergone implantation to date. It is used as a visual prosthesis to improve the vision of people with severe cases of retinitis pigmentosa. The fdas green light for second sights argus ii retinal prosthesis system gives hope to. Jul 22, 2015 agerelated macular degeneration patient receives bionic eye transplant by chris wood. Retinal implants implant uses electrical stimulation to bypass defective photoreceptors and stimulate remaining viable retinal cells.
Fda approval for argus ii retinal prosthesis system. As such it has entered the commercial market as a treatment for patients with profound vision loss from endstage outer retinal disease, predominantly retinitis pigmentosa. As a retina specialist, i provide retinal services within different ophthalmology practices in the northern virginia area, including. Argus ii archives retina specialist fairfax, virginia. The argus ii retinal prosthesis system second sight medical products, sylmar, ca is the first and only retinal prosthesis to have authorities approvals for commercialization in the european economic area, the united states, and canada. Argus ii is the worlds first evercommercial implant.
Today, a considerable number of patients are using argus ii retinal prosthesis to regain some functional vision assisting them to make their way in the world. Our study shows that this unique stem cellbased retinal implant thus far is welltolerated, and preliminary results suggest it may help people with advanced dry agerelated macular degeneration, said coauthor and lead inventor of the implant dr. Another epiretinal device, the learning retinal implant, has been developed by iip technologies gmbh, and has begun to be evaluated in clinical trials. The argus ii retinal prosthesis system second sight medical products, inc. As coinventors, they converged the concepts of both bioengineering and medicine to develop the argus ii retinal prosthesis system, which is a medical. Argus ii is the worlds first evercommercial implant intended to. Argus retinal prosthesis, also known as a bionic eye, is an electronic retinal implant manufactured by the american company second sight medical products. Jan 14, 2015 collins was later referred to emorys retina service, and just this year received a letter indicating he might be a good candidate for a new groundbreaking procedure for those patients who are blind from rp. Correct coding argus ii retinal prosthesis system noridian. During months of followup testing, kulik will train her brain to see in a new way, interpreting the signals sent by argus ii. The argus ii, a retinal implant intended for patients with degenerative eye disorders, has successfully completed a threeyear clinical trial. Argus ii clinical trials recruited patients with retinitis pigmentosa or other outer retinal degeneration with bare or no light perception logmar 2. Image data from an external camera is wirelessly transmitted to the implant which stimulates electrodes in an array on the retina to produce visual percepts.
Second sights argus ii retinal prosthesis system gives hope to those blinded by a rare genetic eye condition called advanced retinitis pigmentosa, which. Retinal prostheses for restoration of sight to patients blinded by retinal degeneration are being. With the argus ii retinal prosthesis by paul hahn, md, phd. Retinal implant for macular degeneration tested in first. Second sight announces record number of argus ii retinal. Jul 22, 2015 second sight announces first agerelated macular degeneration patient receives the argus ii retinal prosthesis system as part of groundbreaking study. The argus ii retinal prosthesis system is a visual prosthesis that. A retinal implant that is more effective against blindness duration. It is attached to the retina over the macula with a retinal tack.
A retinal implant system that is capable of restoring some sight to adults who have lost their vision due to retinitis pigmentosa. Those currently in or near human testing include boston retinal implant project, or brip boston, a cofounder of the field along with second sight sylmar, calif. The 60electrode array is surgically implanted on the epiretinal side of the retina fig. The image shown in f is what argus ii was able to capture for lisa that day.
Enrollment has been completed in a feasibility trial to test the safety and utility of the argus ii in individuals with dry agerelated macular degeneration. Retina today surgical pearls for implantation of the argus. Michael jumper, md, spoke with mark humayun about the argus ii and its practical implications for asrs members and patients. Argus ii received approval from the us fda on april 14, 20 fda approval. These external replacement parts are not billable to the dme mac even if the device is being used in the home.
Humayun, md, phd, who has devoted 25 years to its research and development. Dec 08, 2015 the argus ii was the first retinal implant to receive ce marking, and the only implant granted an fda approval as a humanitarian use device. Intraoperative oct imaging of the argus ii retinal prosthesis. The development of a retinal implant was the brainchild of asrs executive committee and board member mark s. The argus ii, a retinal implant intended for patients.
Renowned vitreoretinal surgeon, njretinas paul hahn, md, phd has brought a cuttingedge, fdaapproved implant procedure, the argus ii retina prosthesis system, to new jersey. The argus ii retinal implant, manufactured by second sight medical products received market approval in the us in feb 20 and in europe in feb 2011, becoming the first approved implant. The purpose of this study is to test the argus ii retinal prosthesis system in patients with severe agerelated macular degeneration amd. Sep 22, 2016 argus ii retinal prosthesis system correct coding. Four more patients with dry macular degeneration will receive a retinal implant called the argus ii retinal prosthesis. The argus ii retinal prosthesis system, built by secondsight, is designed to stimulate a. Second sight announces positive fiveyear data from argus. The costeffectiveness of the argus ii retinal prosthesis. Fda approval for marketing under this indication was granted on february, 20.
Argus ii is the worlds first evercommercial implant intended to restore some vision in the. To date, argus ii artificial retina is implanted in four patients in iran. Second sight announces first agerelated macular degeneration. The device is a prosthesis, a retinal implant, that can provide stimulation of the retina to induce visual perception in blind individuals. The argus ii retinal prosthesis bionic eye receives. Retinitis pigmentosa rp is a hereditary genetic disease causing bilateral retinal degeneration.